← Back
Data updated: Mar 10, 2026
EPIZYME INC
OncologyGastroenterology
EPIZYME INC is a pharmaceutical company focused on Oncology, Gastroenterology. Key products include TAZVERIK.
2020
Since
1
Drugs
-
Trials
1
Approved (2yr)
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 96%
1 drugs Phase 3: 1 Phase 2: 3 Phase 1: 9
Gastroenterology 4%
0 drugs Phase 1: 1
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2020-01-23
- Latest
- 2024-08-13
- Applications
- 2